Skip to product information
1 of 1

Elabscience

SKU:PKSH031809

Recombinant Human NBL1/DAND1 Protein (Fc Tag)(Active)

Recombinant Human NBL1/DAND1 Protein (Fc Tag)(Active)

Regular price $609.00 USD
Regular price Sale price $609.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human NBL1/DAND1 Protein (Fc Tag)(Active), a cutting-edge product meticulously engineered to revolutionize the field of biotechnology. This exceptional protein, derived from human sources, boasts an active nature that ensures optimal functionality and efficacy.

Crafted through the process of recombinant technology, this protein is endowed with a fusion of the Fc tag, further enhancing its stability and facilitating ease of purification. With its active properties, this protein exhibits remarkable potential in various applications, including but not limited to research, drug development, and therapeutic interventions.

The Recombinant Human NBL1/DAND1 Protein (Fc Tag)(Active) is meticulously manufactured under stringent quality control measures, guaranteeing its purity, integrity, and consistency. Its active form enables it to interact with target molecules, thereby facilitating crucial biological processes and unraveling intricate molecular mechanisms.

This groundbreaking protein holds immense promise in elucidating the intricate pathways involved in various diseases, paving the way for novel therapeutic interventions. Its active nature empowers researchers and scientists to delve deeper into the realms of cellular and molecular biology, unraveling the mysteries that lie within.

In conclusion, the Recombinant Human NBL1/DAND1 Protein (Fc Tag)(Active) is a remarkable scientific breakthrough, offering unparalleled potential in the realms of biotechnology. Its active properties, coupled with the fusion of the Fc tag, render it an indispensable tool for researchers, scientists, and pharmaceutical professionals alike. Embrace this cutting-edge protein and unlock the doors to a world of limitless possibilities.
View full details